From Access to Adherence: The Challenges of Antiretroviral Treatment - Studies from Botswana, Tanzania and Uganda, 2006: 3. From training to action: the process of engaging health professionals in operational research on adherence to antiretroviral therapy: References

From Access to Adherence: The Challenges of Antiretroviral Treatment - Studies from Botswana, Tanzania and Uganda, 2006
(2006; 320 pages)

Índice de contenido

Acknowledgments
Acronyms and abbreviations
Foreword
1. On hunger, transport costs and waiting time: a synthesis of challenges to ARV adherence in three African countries
	Introduction
	Methods
	Discussion
	Conclusion
	References
2. Overview of antiretroviral therapy, adherence and drug-resistance
	Background
	References
3. From training to action: the process of engaging health professionals in operational research on adherence to antiretroviral therapy
	Introduction
	Promoting the rational use of drugs
	Promoting Rational Drug Use in the Community course
	Three ARV adherence studies: the process
	How the process was funded
	Discussion and conclusion
	References
	Annex 1: PRDUC course participants by region, type of institution, sex and source of funding
	Annex 2: URLs for country proposals
	Annex 3: Call for proposals
4. There's hope - early observations of ARV treatment roll-out in South Africa
Factors that facilitate or constrain adherence to antiretroviral therapy among adults at four public health facilities in Botswana: a pre-intervention study
	Acknowledgements
	Acronyms and abbreviations
	Executive summary
	Chapter 1: Introduction
		1.1 Research problem
		1.2 Research questions
		1.3 Study objectives
	Chapter 2: Background
		2.1 History of HIV and AIDS in Botswana
		2.2 Botswana's ART programme
		2.3 Literature review
		2.4 Definition of concepts
	Chapter 3: Methodology
		3.1 Introduction
		3.2 Study design
		3.3 Study population
		3.4 Description of study sites
		3.5 Inclusion and exclusion criteria
		3.6 Selection and training of data collectors
		3.7 Qualitative data collection
		3.8 Observations
		3.9 Semi-structured interviews
		3.10 Exit interviews
		3.11 Focus group discussions
		3.12 Quantitative data
		3.13 Data analysis
		3.14 Emic perspective
		3.15 Ethical considerations
		3.16 Feedback
	Chapter 4: Quantitative results
		4.1 Adherence measurement tool results
		4.2 Rates of adherence to ARVs
		4.3 Reasons for skipping medication
		4.4 Factors affecting adherence to ART
		4.5 Predictors of adherence to ART
		4.6 Quantitative results of exit interviews
	Chapter 5: Qualitative results
		5.1 Constraints to adherence to ART
		5.2 Facilitators of adherence to ART
		5.3 Observation of health facilities 5.3.1 Structural issues
		5.4 National level policy issues
	Chapter 6: Discussion, conclusion and recommendations
		6.1 Discussion
		6.2 Conclusions
		6.3 Recommendations
	References
	Annex 1: Mean of rates adherence
	Annex 2: Multivariate logistic regression analyses on the predictor variables
	Annex 3: Questionnaires
A study on antiretroviral adherence in Tanzania: a pre-intervention perspective, 2005
	Acknowledgements
	Acronyms and abbreviations
	Executive summary
	Chapter 1: Introduction
		1.1 Background
		1.2 Rationale
		1.3 Literature review
		1.4 Problem statement
		1.5 Objectives
		1.6 Output
	Chapter 2: Methodology
		2.1 Study design
		2.2 Study population
		2.3 Inclusion and exclusion criteria for interviewees
		2.4 Quantitative data
		2.5 Qualitative data
		2.6 Data collection tools
		2.7 Pilot study
		2.8 Sample size and sampling strategy
		2.9 Data collection
		2.10 Ethics
	Chapter 3: Study areas
		3.1 Health care facilities
	Chapter 4: Quantitative results
		4.1 Demographic characteristics of ARV users
		4.2 Adherence rates
	Chapter 5: Qualitative results
		5.1 Factors that influence adherence to ARVs from the users' perspective
		5.2 Quality of operating structures
		5.3 Opinions and suggestions given by respondents to improve provision of ARVs
	Chapter 6: Discussion, conclusion and recommendations
		6.1 Discussion
		6.2 Conclusion
		6.3 Recommendations
		6.4 Proposed interventions
	References
	Annex 1: Exit interview with ARV users
	Annex 2: Semi-structured interview with ARV users
	Annex 3: ARV users, FGDs
	Annex 4: Adherence measurement tools
	Annex 5: Key informant interview
	Annex 6: Semi-structured interviews (with staff)
	Annex 7: Observation (consultations)
	Annex 8: Observation of antiretroviral
Factors that facilitate or constrain adherence to antiretroviral therapy among adults in Uganda: a pre-intervention study
	Acknowledgements
	Glossary
	Executive summary
	Chapter 1: Introduction
		1.1 Background
		1.2 Research problem
		1.3 Research objective
	Chapter 2: Background to the study
		2.1 History of AIDS in Uganda
		2.2 History of ARVs in Uganda
	Chapter 3: Literature review
		3.1 Importance of adherence to ART
		3.2 Measurement of adherence
		3.3 Factors affecting adherence to ART
		3.4 Impact of the drug regimen on adherence
		3.5 Treatment characteristics affecting adherence 3.5.1 Physical state and disease stage
		3.6 The clinic setting and service provision
		3.7 Simplifying treatment regimes to improve adherence
		3.8 Conceptual framework
	Chapter 4: Methodology
		4.1 Study design
		4.2 Study population
		4.3 Inclusion and exclusion criteria
		4.4 Sample size and selection
		4.5 Data collector selection and training
		4.6 Pilot testing
		4.7 Data collection
		4.8 Data analysis
		4.9 Evaluation of methods
		4.10 Ethical considerations
	Chapter 5: Description of the study sites
		5.1 Jinja Regional Referral Hospital
		5.2 Nile Treatment Centre
		5.3 Study limitations
	Chapter 6: Results
		6.1 Demographic characteristics of ARV users
		6.2 Factors influencing adherence to ART
	Chapter 7: Discussion, conclusions and recommendations
		7.1 Discussion
		7.2 Conclusions
		7.3 Recommendations
	References
Back cover

References

1. Abah SJ et al. (2005). There's hope - early observations of ARV treatment roll out in South Africa. Essential Drugs Monitor No.34:16-17.

2. Adome RO, Reynolds-Whyte S, Hardon A (1996). Popular pills. Community drug use in Uganda. Community Drug Use Studies. Amsterdam, Het Spinhuis, 1996.

3. Birungi, H. Injection use and practices in Uganda. Geneva, World Health Organization, 1995.

4. Farmer KC (1999). Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clinical Therapeutics, 21(6):1074-1090.

5. Haaland A, Molyneux C. Collecting quality information: training manual on practical communication skills for researchers and project personnel. Geneva, World Health Organization, 2005.

6. Hardon A. Confronting ill health: medicines, self-care and the poor in Manila. Quezon City, Health Action Information Network, 1990.

7. Hardon AP, Hodgkin C, Fresle D (2004). How to investigate the use of medicines by consumers. Geneva, World Health Organization, 2004.

8. Hardon A et al. Manual for applied health research. Anthropology of health and health care. Amsterdam, Het Spinhuis, 2001.

9. Hogerzeil HV et al.(1993). Field tests for rational drug use in twelve developing countries. Lancet, 4 December:1408-1410.

10. Kasper T et al. (2003). Demystifying antiretroviral therapy in resource-poor settings. World Health Organization Essential Drugs Monitor No.32:20-21.

11. Paterson DL et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133:21-30.

12. Population Council Horizons (2005). Testing different approaches to promoting adherence to HAART in Mombasa, Kenya. Available at: http://www.popcouncil.org/horizons/AIDSquest/summaries/ssmombasaARVs.html

13. Rasmussen ZA et al. Enhancing appropriate medicine use in the Karakoram mountains. Community Drug Use Studies. Amsterdam, Het Spinhuis, 1996.

14. Richard N et al. (2004). High prevalence of antiretroviral resistance in treated Ugandans infected with Non-subtype B Human Immunodeficiency Virus Type 1. AIDS Research and Human Retroviruses, 20(4):355-364.

15. Sankar A et al. (2002). Adherence discourse among African-American women taking HAART. AIDS Care, 14(2):203-218.

16. Senah KA. The popularity of medicines in a rural Ghanaian community. Community drug use studies. Amsterdam, Het Spinhuis, 1997.

17. Sringernyuang L. Availability and use of medicines in rural Thailand. University of Amsterdam, 2000 [Dissertation].

18. van Staa A, Hardon A. Injection practices in the developing world: a comparative review of field studies in Uganda and Indonesia. Geneva, World Health Organization, 1996.

19. Vitolins MZ et al. (2000). Measuring adherence to behavioral and medical interventions. Controlled Clinical Trials, 21:188S-194S.

20. WHO (1985). Rational use of drugs. Report of the Conference of Experts, Nairobi, Kenya, 25-29 November. Geneva, World Health Organization.

21. WHO (1992). How to investigate drug use in communities. Geneva, World Health Organization.

22. WHO (1993). How to investigate drug use in health facilities. Geneva, World Health Organization.

23. WHO (1997). Public education in rational drug use. Geneva, World Health Organization.

24. WHO (2002). Promoting rational use of medicines: core components. WHO Policy Perspectives on Medicines, No.5. Geneva, World Health Organization.